Á Rovirosa1,2, K S Cortés3, C Ascaso4, A Glickman5, S Valdés5, A Herreros3, C Camacho3, J Sánchez6, Y Zhang7, Y Li7, S Sabater8, M Arenas9, A Torne5. 1. Radiation Oncology Department, Hospital Clínic Universitari, C/Villarroel 170, 08036, Barcelona, Spain. rovirosa@clinic.ub.es. 2. Gynecological Cancer Unit, Hospital Clínic Universitari, Barcelona, Spain. rovirosa@clinic.ub.es. 3. Radiation Oncology Department, Hospital Clínic Universitari, C/Villarroel 170, 08036, Barcelona, Spain. 4. Health Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain. 5. Gynecological Cancer Unit, Hospital Clínic Universitari, Barcelona, Spain. 6. Economics Department, Hospital Clinic Universitari, Barcelona, Spain. 7. Fonaments Clinics, Faculty of Medicine, University of Barcelona, Barcelona, Spain. 8. Radiation Oncology Department, Hospital General de Albacete, Albacete, Spain. 9. Radiation Oncology Department, Hospital Sant Joan de Reus, Reus, Spain.
Abstract
OBJECTIVE: To analyze the impact of age on radiotherapy results based on cancer-specific survival (CSS), vaginal-cuff relapses (VCR) and complications analysis in 438 patients with endometrial carcinoma (EC) receiving postoperative radiotherapy (PRT) divided into three age groups for analysis. MATERIALS AND METHODS: From 2003 to 2015, 438 patients with EC were treated with PRT and divided into three age groups: Group-1: 202 patients < 65 years; Group-2: 210 patients ≥ 65 and < 80 years; Group-3: 26 patients ≥ 80 years. Vaginal toxicity was assessed using the objective LENT-SOMA criteria and RTOG scores were recorded for the rectum, bladder, and small bowel. STATISTICS: Chi square and Student's t tests, Kaplan-Meier survival study for analysis of CSS. RESULTS: The mean follow-up was 5.6 years in Group-1, 5.6 years in Group-2 and 6.3 years in Group-3 (p = 0.38). No differences were found among the groups in distribution of stage, grade, myometrial invasion, Type 1 vs. 2 EC and VLSI (p = 0.97, p = 0.52, p = 0.35, p = 0.48, p = 0.76, respectively). There were no differences in rectal, bladder and vagina late toxicity (p = 0.46, p = 0.17, p = 0.75, respectively). A better CSS at 5 years was found in Group-1 (p = 0.006), and significant differences were found in late severe small bowel toxicity in Group-3 (p = 0.005). VCR was increased in Group-3 (p = 0.017). CONCLUSIONS: Patients ≥ 65 years had a worse outcome in comparison to younger patients. Late vaginal, rectal and bladder toxicities were similar in the three groups, although an increase of severe late small bowel toxicity led to IMRT in patients ≥ 80 years. Further larger studies are needed including quality of life analysis in patients ≥ 80 years.
OBJECTIVE: To analyze the impact of age on radiotherapy results based on cancer-specific survival (CSS), vaginal-cuff relapses (VCR) and complications analysis in 438 patients with endometrial carcinoma (EC) receiving postoperative radiotherapy (PRT) divided into three age groups for analysis. MATERIALS AND METHODS: From 2003 to 2015, 438 patients with EC were treated with PRT and divided into three age groups: Group-1: 202 patients < 65 years; Group-2: 210 patients ≥ 65 and < 80 years; Group-3: 26 patients ≥ 80 years. Vaginal toxicity was assessed using the objective LENT-SOMA criteria and RTOG scores were recorded for the rectum, bladder, and small bowel. STATISTICS: Chi square and Student's t tests, Kaplan-Meier survival study for analysis of CSS. RESULTS: The mean follow-up was 5.6 years in Group-1, 5.6 years in Group-2 and 6.3 years in Group-3 (p = 0.38). No differences were found among the groups in distribution of stage, grade, myometrial invasion, Type 1 vs. 2 EC and VLSI (p = 0.97, p = 0.52, p = 0.35, p = 0.48, p = 0.76, respectively). There were no differences in rectal, bladder and vagina late toxicity (p = 0.46, p = 0.17, p = 0.75, respectively). A better CSS at 5 years was found in Group-1 (p = 0.006), and significant differences were found in late severe small bowel toxicity in Group-3 (p = 0.005). VCR was increased in Group-3 (p = 0.017). CONCLUSIONS:Patients ≥ 65 years had a worse outcome in comparison to younger patients. Late vaginal, rectal and bladder toxicities were similar in the three groups, although an increase of severe late small bowel toxicity led to IMRT in patients ≥ 80 years. Further larger studies are needed including quality of life analysis in patients ≥ 80 years.
Authors: Supriya Gupta Mohile; Ying Xian; William Dale; Susan G Fisher; Miriam Rodin; Gary R Morrow; Alfred Neugut; William Hall Journal: J Natl Cancer Inst Date: 2009-07-28 Impact factor: 13.506
Authors: Angeles Rovirosa; Carlos Ascaso; Alberto Sánchez-Reyes; Antonio Herreros; Rosa Abellana; Jaume Pahisa; Jose Antonio Lejarcegui; Albert Biete Journal: Int J Radiat Oncol Biol Phys Date: 2010-08-26 Impact factor: 7.038
Authors: A Gómez Portilla; C Martínez de Lecea; I Cendoya; I Olabarría; E Martín; L Magrach; E Romero; J Cortés; J Muriel; A Márquez; M Kvadatze Journal: Rev Esp Enferm Dig Date: 2008-11 Impact factor: 2.086
Authors: J Alejandro Rauh-Hain; Kristen J Pepin; Larissa A Meyer; Joel T Clemmer; Karen H Lu; Laurel W Rice; Shitanshu Uppal; John O Schorge; Marcela G Del Carmen Journal: Obstet Gynecol Date: 2015-12 Impact factor: 7.661
Authors: Yaowen Zhang; Carlos Ascaso; Antonio Herreros; Joan Sánchez; Sebastia Sabater; Marta Del Pino; Yan Li; Gabriela Gómez; Aureli Torné; Albert Biete; Ángeles Rovirosa Journal: Rep Pract Oncol Radiother Date: 2020-01-14